Predictors of postoperative mortality, morbidity, and long-term survival after palliative resection in patients with colorectal cancer
- PMID: 21471753
- DOI: 10.1007/DCR.0b013e3182083d9d
Predictors of postoperative mortality, morbidity, and long-term survival after palliative resection in patients with colorectal cancer
Abstract
Background: Limited information is available on predictors of postoperative mortality, morbidity, and long-term survival in patients with stage IV colorectal cancer.
Objective: This study aimed to identify independent predictors of postoperative mortality and morbidity as well as independent predictors of long-term survival.
Design: This study was planned as a retrospective single-institution review.
Setting: This study took place at the Department of Surgery, The Royal Brisbane and Women's Hospital, Australia, between 1984 and 2004.
Participants: Prospectively collected data were extracted from the records of 1867 patients undergoing treatment for colorectal cancer. The outcomes for 379 patients undergoing surgical resection of their primary colon or rectal tumor in the presence of unresectable synchronous metastases were analyzed.
Main outcome measures: Independent predictive factors for postoperative mortality and morbidity as well as long-term survival were assessed by use of logistic regression and Cox regression analysis.
Results: Thirty-five (9.2%) patients died in the postoperative period and morbidity was 48.3%. Median survival was 11 months. Thirty-day postoperative mortality was independently associated with medical complications (P < .001), emergency operations (P = .001), female sex (P = .002), and age (≥ 70; P = .007) on regression analysis. Elderly (≥ 70) patients with either advanced local disease or extrahepatic metastases were at a particularly high risk. Preoperative predictors of surgical morbidity included male sex (P = .028) and advanced local disease (P = .036). Preoperative predictors of medical complications included repeat operations (P < .001), elevated urea levels (P = .017), and emergency operations (P = .003). Independent factors associated with poor overall survival included medical complications (P < .001), nodal stage (N2) (P = .004), poor tumor differentiation (P = .006), and apical lymph node involvement (P = .042). A subgroup of patients with advanced nodal disease (N2) and a poor tumor differentiation had a significantly poorer prognosis.
Limitations: This study was limited by its retrospective nature.
Conclusion: Elderly patients with advanced local disease or extrahepatic metastases are at high risk of 30-day postoperative mortality. Significant nodal disease and poor tumor differentiation are important predictors of long-term survival.
Similar articles
-
[Clinical analysis of patients with stage IV ( colorectal cancer after palliative resection of primary tumor].Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Dec;15(12):1282-6. Zhonghua Wei Chang Wai Ke Za Zhi. 2012. PMID: 23268278 Chinese.
-
Aspects of survival from colorectal cancer in Denmark.Dan Med J. 2012 Apr;59(4):B4428. Dan Med J. 2012. PMID: 22459726
-
Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.World J Surg Oncol. 2007 Jul 4;5:73. doi: 10.1186/1477-7819-5-73. World J Surg Oncol. 2007. PMID: 17610720 Free PMC article.
-
[Meta-analysis of laparoscopic versus open surgery for palliative resection of the primary tumor in stage IV colorectal cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jun 25;23(6):589-596. doi: 10.3760/cma.j.cn.441530-20190619-00247. Zhonghua Wei Chang Wai Ke Za Zhi. 2020. PMID: 32521980 Chinese.
-
Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review.Int J Colorectal Dis. 2008 Jun;23(6):559-68. doi: 10.1007/s00384-008-0456-6. Epub 2008 Mar 11. Int J Colorectal Dis. 2008. PMID: 18330581 Review.
Cited by
-
Laparoscopy is not enough: full ERAS compliance is the key to improvement of short-term outcomes after colectomy for cancer.Surg Endosc. 2020 May;34(5):2067-2075. doi: 10.1007/s00464-019-06987-5. Epub 2019 Aug 5. Surg Endosc. 2020. PMID: 31385073
-
Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells.Nutrients. 2016 Mar 5;8(3):145. doi: 10.3390/nu8030145. Nutrients. 2016. PMID: 26959057 Free PMC article.
-
The management of rectal cancer with synchronous liver metastases: a modern surgical dilemma.Tech Coloproctol. 2013 Feb;17(1):1-12. doi: 10.1007/s10151-012-0888-4. Epub 2012 Sep 26. Tech Coloproctol. 2013. PMID: 23011160 Review.
-
Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study.JNCI Cancer Spectr. 2017 Nov 28;1(1):pkx009. doi: 10.1093/jncics/pkx009. eCollection 2017 Sep. JNCI Cancer Spectr. 2017. PMID: 31360835 Free PMC article.
-
Impact of postoperative complications after primary tumor resection on survival in patients with incurable stage IV colorectal cancer: A multicenter retrospective cohort study.Ann Gastroenterol Surg. 2021 Jan 25;5(3):354-362. doi: 10.1002/ags3.12433. eCollection 2021 May. Ann Gastroenterol Surg. 2021. PMID: 34095726 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical